Richard N. Yu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vesico-Ureteral Reflux | 7 | 2016 | 424 | 0.950 |
Why?
|
| Sexual Development | 2 | 2021 | 37 | 0.860 |
Why?
|
| Infertility, Male | 3 | 2019 | 408 | 0.840 |
Why?
|
| Semen Preservation | 1 | 2019 | 35 | 0.750 |
Why?
|
| Cryopreservation | 3 | 2021 | 635 | 0.720 |
Why?
|
| Disorders of Sex Development | 2 | 2021 | 122 | 0.690 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2016 | 172 | 0.580 |
Why?
|
| Health Facilities | 1 | 2020 | 467 | 0.570 |
Why?
|
| Penis | 1 | 2016 | 218 | 0.550 |
Why?
|
| Dextrans | 2 | 2006 | 617 | 0.520 |
Why?
|
| Resuscitation Orders | 1 | 2016 | 273 | 0.510 |
Why?
|
| Sperm Banks | 1 | 2012 | 7 | 0.470 |
Why?
|
| Bupivacaine | 1 | 2016 | 427 | 0.460 |
Why?
|
| Hyaluronic Acid | 2 | 2006 | 500 | 0.460 |
Why?
|
| Ureter | 4 | 2016 | 363 | 0.410 |
Why?
|
| Urologic Diseases | 2 | 2012 | 252 | 0.400 |
Why?
|
| Nephrectomy | 1 | 2016 | 1001 | 0.400 |
Why?
|
| Semen Analysis | 1 | 2012 | 227 | 0.380 |
Why?
|
| Nerve Block | 1 | 2016 | 638 | 0.380 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 991 | 0.360 |
Why?
|
| Laparoscopy | 2 | 2017 | 1996 | 0.340 |
Why?
|
| Replantation | 2 | 2016 | 149 | 0.280 |
Why?
|
| Ureteroscopy | 1 | 2006 | 121 | 0.280 |
Why?
|
| Klinefelter Syndrome | 2 | 2015 | 45 | 0.270 |
Why?
|
| Sperm Retrieval | 2 | 2015 | 18 | 0.260 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2018 | 323 | 0.260 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2785 | 0.250 |
Why?
|
| Microspheres | 1 | 2006 | 800 | 0.250 |
Why?
|
| Colpotomy | 1 | 2022 | 13 | 0.230 |
Why?
|
| Urogenital Abnormalities | 2 | 2017 | 250 | 0.230 |
Why?
|
| Survivors | 1 | 2012 | 2166 | 0.210 |
Why?
|
| Varicocele | 1 | 2021 | 74 | 0.210 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2021 | 101 | 0.210 |
Why?
|
| Cryptorchidism | 1 | 2021 | 123 | 0.210 |
Why?
|
| Turner Syndrome | 1 | 2021 | 127 | 0.200 |
Why?
|
| Sex Reassignment Surgery | 1 | 2022 | 90 | 0.190 |
Why?
|
| DNA | 1 | 2014 | 7166 | 0.190 |
Why?
|
| Hypogonadism | 2 | 2017 | 768 | 0.190 |
Why?
|
| Urinary Tract | 2 | 2013 | 295 | 0.190 |
Why?
|
| Urethral Stricture | 1 | 2017 | 58 | 0.170 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2017 | 90 | 0.160 |
Why?
|
| Urology | 2 | 2012 | 371 | 0.150 |
Why?
|
| Endoscopy | 1 | 2006 | 1758 | 0.150 |
Why?
|
| Stem Cells | 1 | 2009 | 3597 | 0.150 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 769 | 0.140 |
Why?
|
| Gels | 2 | 2006 | 437 | 0.140 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 11951 | 0.140 |
Why?
|
| Adolescent | 16 | 2021 | 85139 | 0.130 |
Why?
|
| Prostate | 1 | 2022 | 1604 | 0.120 |
Why?
|
| Child | 15 | 2021 | 74387 | 0.120 |
Why?
|
| Neoplasms | 2 | 2019 | 20568 | 0.110 |
Why?
|
| Infant | 6 | 2021 | 34574 | 0.110 |
Why?
|
| Male | 24 | 2022 | 351380 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2017 | 4654 | 0.100 |
Why?
|
| GATA6 Transcription Factor | 1 | 2010 | 48 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 1666 | 0.100 |
Why?
|
| Consensus | 1 | 2019 | 2755 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2017 | 2300 | 0.100 |
Why?
|
| Humans | 29 | 2022 | 717237 | 0.090 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 138 | 0.090 |
Why?
|
| Hormone Replacement Therapy | 1 | 2015 | 740 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2017 | 41221 | 0.090 |
Why?
|
| Young Adult | 10 | 2022 | 56247 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 202 | 0.090 |
Why?
|
| Urothelium | 1 | 2010 | 289 | 0.080 |
Why?
|
| Germ Cells | 1 | 2011 | 595 | 0.080 |
Why?
|
| Tretinoin | 1 | 2010 | 530 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2013 | 781 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 1633 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 282 | 0.070 |
Why?
|
| Therapeutic Irrigation | 1 | 2006 | 306 | 0.070 |
Why?
|
| Physician's Role | 1 | 2012 | 977 | 0.070 |
Why?
|
| Pediatrics | 2 | 2017 | 3556 | 0.070 |
Why?
|
| Testosterone | 1 | 2015 | 2356 | 0.060 |
Why?
|
| Urologic Surgical Procedures | 2 | 2017 | 293 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5152 | 0.060 |
Why?
|
| Forecasting | 2 | 2010 | 2948 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 876 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 813 | 0.060 |
Why?
|
| Orchiopexy | 1 | 2021 | 14 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1385 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2021 | 72614 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15126 | 0.050 |
Why?
|
| Metaplasia | 1 | 2022 | 310 | 0.050 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 1780 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1650 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2012 | 2595 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 2570 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3807 | 0.050 |
Why?
|
| Orchiectomy | 1 | 2021 | 455 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 1994 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 4872 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4141 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7486 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3082 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 779 | 0.040 |
Why?
|
| Quality of Life | 1 | 2017 | 11760 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 62348 | 0.040 |
Why?
|
| Urination | 1 | 2017 | 201 | 0.040 |
Why?
|
| Boston | 2 | 2021 | 9407 | 0.040 |
Why?
|
| Circumcision, Male | 1 | 2017 | 150 | 0.040 |
Why?
|
| Female | 13 | 2022 | 377909 | 0.040 |
Why?
|
| Physical Examination | 1 | 2021 | 1243 | 0.030 |
Why?
|
| Radiography | 1 | 2006 | 7001 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9532 | 0.030 |
Why?
|
| Adult | 7 | 2022 | 212451 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8282 | 0.030 |
Why?
|
| Androgens | 1 | 2022 | 1231 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2009 | 3273 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2021 | 1573 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2017 | 335 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2006 | 5948 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 815 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2004 | 0.030 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 232 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 126 | 0.030 |
Why?
|
| Somatomedins | 1 | 2011 | 198 | 0.030 |
Why?
|
| Endocrinology | 1 | 2017 | 414 | 0.030 |
Why?
|
| Karyotyping | 1 | 2013 | 1272 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 174 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 315 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 41095 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 390 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 242 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 951 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1506 | 0.020 |
Why?
|
| Living Donors | 1 | 2012 | 574 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1195 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 2369 | 0.020 |
Why?
|
| Ecosystem | 1 | 2011 | 427 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2951 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 2930 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1589 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3532 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 51275 | 0.020 |
Why?
|
| Curriculum | 1 | 2017 | 3403 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4846 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6528 | 0.020 |
Why?
|
| Animals | 3 | 2011 | 170890 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 8066 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7734 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 24742 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39302 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2012 | 2131 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7847 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 27306 | 0.010 |
Why?
|
| Prognosis | 2 | 2012 | 29226 | 0.010 |
Why?
|
| Zebrafish | 1 | 2011 | 3030 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2010 | 6132 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3864 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12483 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18798 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5465 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10451 | 0.010 |
Why?
|
| United States | 2 | 2016 | 67798 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 6051 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3600 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13601 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 13274 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15271 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11777 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13301 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2010 | 5032 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 16017 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20653 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 20095 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16404 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 8109 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22929 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 23542 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 39887 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23996 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 70864 | 0.000 |
Why?
|
| Aged | 1 | 2017 | 162856 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81126 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 215041 | 0.000 |
Why?
|